Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Joost J C Verhoeff
Affiliation
University Medical Center Utrecht
ORCID
Career Start Year
2005
Papers
108
H Index
21
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37652302
A Framework for Assessing the Effect of Cardiac and Respiratory Motion for Stereotactic Arrhythmia Radioablation Using a Digital Phantom With a 17-Segment Model: A STOPSTORM.eu Consortium Study.
Int J Radiat Oncol Biol Phys
2024
36135366
Occurrence, Risk Factors, and Consequences of Postoperative Ischemia After Glioma Resection: A Retrospective Study.
Neurosurgery
2023
37527331
Accelerated respiratory-resolved 4D-MRI with separable spatio-temporal neural networks.
Med Phys
2023
37543057
Stereotactic Arrhythmia Radioablation (STAR): Assessment of cardiac and respiratory heart motion in ventricular tachycardia patients - A STOPSTORM.eu consortium review.
Radiother Oncol
2023
37686575
Evaluating Physiological MRI Parameters in Patients with Brain Metastases Undergoing Stereotactic Radiosurgery-A Preliminary Analysis and Case Report.
Cancers (Basel)
2023
37541279
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups.
Lancet Oncol
2023
37457228
Practice variation in re-resection for recurrent glioblastoma: A nationwide survey among Dutch neuro-oncology specialists.
Neurooncol Pract
2023
37283211
SynthRAD2023 Grand Challenge dataset: Generating synthetic CT for radiotherapy.
Med Phys
2023
37339638
Real-time myocardial landmark tracking for MRI-guided cardiac radio-ablation using Gaussian Processes.
Phys Med Biol
2023
37033340
Efficacy of stereotactic ablative radiotherapy (SABR) during anti-PD-1 in oligoprogressive non-small cell lung cancer and melanoma-a prospective multicenter observational study pointing out new unmet needs.
Transl Cancer Res
2023
37473612
Exploring contrast generalisation in deep learning-based brain MRI-to-CT synthesis.
Phys Med
2023
37066114
The impact of schizophrenia spectrum disorder, bipolar disorder and borderline personality disorder on radiotherapy treatment and overall survival in cancer patients: A matched pair analysis.
Clin Transl Radiat Oncol
2023
36996627
CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma.
Eur J Cancer
2023
36592740
Dosimetric feasibility of direct post-operative MR-Linac-based stereotactic radiosurgery for resection cavities of brain metastases.
Radiother Oncol
2023
36879464
STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe.
Europace
2023
36610310
The impact of etiology in lesion-symptom mapping - A direct comparison between tumor and stroke.
Neuroimage Clin
2023
36843274
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma.
Int J Cancer
2023
36927251
Feasibility and first results of the 'Trials-within-Cohorts' (TwiCs) design in patients undergoing radiotherapy for lung cancer.
Acta Oncol
2023
36210631
On the feasibility of cardiac substructure sparing in magnetic resonance imaging guided stereotactic lung radiotherapy.
Med Phys
2023
34718916
Non-Small-Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection: Can Chemoradiotherapy Offer Similar Survival?
Ann Surg Oncol
2022
35608378
Survival Prediction After Neurosurgical Resection of Brain Metastases: A Machine Learning Approach.
Neurosurgery
2022
35437259
Conventional MRI Criteria to Differentiate Progressive Disease From Treatment-Induced Effects in High-Grade (WHO Grade 3-4) Gliomas.
Neurology
2022
35855455
Complications, compliance, and undertreatment do not explain the relationship between cognition and survival in diffuse glioma patients.
Neurooncol Pract
2022
35427556
In Reply to Chow and Simone.
Int J Radiat Oncol Biol Phys
2022
35393451
Individual treatment effect estimation in the presence of unobserved confounding using proxies: a cohort study in stage III non-small cell lung cancer.
Sci Rep
2022
35817325
First experimental demonstration of VMAT combined with MLC tracking for single and multi fraction lung SBRT on an MR-linac.
Radiother Oncol
2022
36274570
Imaging standardisation in metastatic colorectal cancer: A joint EORTC-ESOI-ESGAR expert consensus recommendation.
Eur J Cancer
2022
35963398
Quantifying the post-radiation accelerated brain aging rate in glioma patients with deep learning.
Radiother Oncol
2022
36096039
Imaging to predict checkpoint inhibitor outcomes in cancer. A systematic review.
Eur J Cancer
2022
35923896
Towards mid-position based Stereotactic Body Radiation Therapy using online magnetic resonance imaging guidance for central lung tumours.
Phys Imaging Radiat Oncol
2022
35887688
The Association between Muscle Quantity and Overall Survival Depends on Muscle Radiodensity: A Cohort Study in Non-Small-Cell Lung Cancer Patients.
J Pers Med
2022
36388422
Screening for long-term complications in brain tumor care, thinking one step ahead.
Neurooncol Pract
2022
36191990
Long-term Local Control and Overall Survival After Radiotherapy in Oligoprogressive Patients During Treatment With Checkpoint Inhibitors.
Anticancer Res
2022
35189610
First experimental exploration of real-time cardiorespiratory motion management for future stereotactic arrhythmia radioablation treatments on the MR-linac.
Phys Med Biol
2022
35287380
Feasibility of cardiac-synchronized quantitative T<sub>1</sub> and T<sub>2</sub> mapping on a hybrid 1.5 Tesla magnetic resonance imaging and linear accelerator system.
Phys Imaging Radiat Oncol
2022
35128399
Irradiation of the subventricular zone and subgranular zone in high- and low-grade glioma patients: an atlas-based analysis on overall survival.
Neurooncol Adv
2022
35243030
Clinical utility of convolutional neural networks for treatment planning in radiotherapy for spinal metastases.
Phys Imaging Radiat Oncol
2022
35243025
The overall survival impact of prophylactic cranial irradiation in limited-stage small-cell lung cancer: A systematic review and meta-analysis.
Clin Transl Radiat Oncol
2022
35083155
Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group - ESOI Joint Paper.
Front Oncol
2022
34806396
Quality of life among patients with 4 to 10 brain metastases after treatment with whole-brain radiotherapy vs. stereotactic radiotherapy: a phase III, randomized, Dutch multicenter trial.
Ann Palliat Med
2022
34456061
Adjuvant Treatment Following Irradical Resection of Stage I-III Non-small Cell Lung Cancer: A Population-based Study.
Curr Probl Cancer
2022
32814843
Long-term outcomes of two ablation techniques for treatment of radio-recurrent prostate cancer.
Prostate Cancer Prostatic Dis
2021
33827065
Simultaneous multi-slice accelerated 4D-MRI for radiotherapy guidance.
Phys Med Biol
2021
33790766
Sarcoma of the Heart Treated with Stereotactic MR-Guided Online Adaptive Radiation Therapy.
Case Rep Oncol
2021
33738451
A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4-10 brain metastases.
Neurooncol Adv
2021
33532631
Combining radiotherapy and focused ultrasound for pain palliation of cancer induced bone pain; a stage I/IIa study according to the IDEAL framework.
Clin Transl Radiat Oncol
2021
33665386
Prophylactic cranial irradiation in patients with small cell lung cancer in The Netherlands: A population-based study.
Clin Transl Radiat Oncol
2021
33777759
Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer.
Front Oncol
2021
33634347
Impact of the COVID-19 pandemic on quality of life and emotional wellbeing in patients with bone metastases treated with radiotherapy: a prospective cohort study.
Clin Exp Metastasis
2021
33631792
The combined use of steroids and immune checkpoint inhibitors in brain metastasis patients: a systematic review and meta-analysis.
Neuro Oncol
2021
1 - 50 of 108
Column Actions
Search
Recommended Authors
Matthew S Susko
University of California San Francisco
Career Start Year
2016
Number of shared co-authors
0
Erqi L Pollom
Stanford University
Career Start Year
2014
Number of shared co-authors
0
Johannes Kerschbaumer
Medical University of Innsbruck
Career Start Year
2012
Number of shared co-authors
1
Jeffrey Greenspoon
Juravinski Cancer Centre
Career Start Year
2011
Number of shared co-authors
0
Nikhil T Sebastian
Emory University
Career Start Year
2011
Number of shared co-authors
0
Hanbo Chen
University of Toronto
Career Start Year
2010
Number of shared co-authors
2
Christian F Freyschlag
Medical University of Innsbruck
Career Start Year
2010
Number of shared co-authors
1
Julia Furtner
Medical University of Vienna
Career Start Year
2009
Number of shared co-authors
1
Martha Nowosielski
Medical University of Innsbruck
Career Start Year
2009
Number of shared co-authors
0
Rohan Ramakrishna
Weill Cornell Medical College, New York Presbyterian Hospital
Career Start Year
2009
Number of shared co-authors
0
Nicholas Butowski
University of California san francisco
Career Start Year
2005
Number of shared co-authors
1
Sherise D Ferguson
The University of Texas MD Anderson Cancer Center
Career Start Year
2005
Number of shared co-authors
0
Martin Glas
University Hospital Essen
Career Start Year
2002
Number of shared co-authors
0
Raymond Y Huang
Brigham and Women's Hospital, Harvard Medical School
Career Start Year
2002
Number of shared co-authors
2
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year
2001
Number of shared co-authors
0
Michelle Alonso-Basanta
Perelman School of Medicine, University of Pennsylvania
Career Start Year
2000
Number of shared co-authors
0
David A Palma
University of Western Ontario
Career Start Year
2000
Number of shared co-authors
2
Steve E Braunstein
University of California san francisco
Career Start Year
1998
Number of shared co-authors
2
Helen A Shih
Massachusetts General Hospital and Harvard Medical School
Career Start Year
1997
Number of shared co-authors
2
John H Suh
Taussig Cancer Institute, Cleveland Clinic
Career Start Year
1994
Number of shared co-authors
0
Clark C Chen
University of Minnesota
Career Start Year
1994
Number of shared co-authors
0
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year
1994
Number of shared co-authors
2
Ganesh Rao
The University of Texas M.D. Anderson Cancer Center
Career Start Year
1994
Number of shared co-authors
0
Timothy F Cloughesy
David Geffen School of Medicine, University of California Los Angeles
Career Start Year
1992
Number of shared co-authors
1
Karin Dieckmann
Medical University of Vienna
Career Start Year
1991
Number of shared co-authors
2
Roger Stupp
Northwestern University
Career Start Year
1990
Number of shared co-authors
2
Michael A Vogelbaum
Moffit Cancer Center
Career Start Year
1986
Number of shared co-authors
0
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year
1982
Number of shared co-authors
0
Penny K Sneed
University of California San Francisco
Career Start Year
1981
Number of shared co-authors
0
John P Kirkpatrick
Duke University Medical Center
Career Start Year
1978
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Lukas J A Stalpers
Co-authored papers
11
Marike L D Broekman
Leiden University Medical Center, Haaglanden Medical Center
Co-authored papers
11
Vasileios K Kavouridis
St Olavs University Hospital
Co-authored papers
6
Dirk De Ruysscher
Maastro Clinic
Co-authored papers
5
Jan Paul Medema
Oncode Institute
Co-authored papers
4
Steven H Lin
University of Texas MD Anderson Cancer Center
Co-authored papers
4
Paul J van Diest
University Medical Center Utrecht
Co-authored papers
3
Tijana Borovski
Cancer Center, University Medical Center Utrecht
Co-authored papers
3
Nancy U Lin
Co-authored papers
2
Laurence Collette
Belgium International Drug Development Institute
Co-authored papers
2
Wouter van Elmpt
Maastricht University Medical Center+
Co-authored papers
2
Mitko Veta
Eindhoven University of Technology
Co-authored papers
2
Louis Vermeulen
Oncode Institute
Co-authored papers
2
Philippe Lambin
Maastricht University
Co-authored papers
2
Shiva M Nair
University of Western Ontario
Co-authored papers
1
Kun-Hsing Yu
Harvard Medical School
Co-authored papers
1
Priscilla K Brastianos
Co-authored papers
1
Esther G C Troost
German Cancer Research Center (DKFZ)
Co-authored papers
1
Omar Arnaout
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers
1
Lev Naumov
Co-authored papers
1
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers
1
Joseph L Chin
University of Western Ontario
Co-authored papers
1
Barbro Linderholm
Sahlgrenska University Hospital
Co-authored papers
1
Marco Mammi
Santa Croce e Carle Hospital
Co-authored papers
1
Andrea Sottoriva
The Institute of Cancer Research, UK Computational Biology Research Centre
Co-authored papers
1
Nick F Ramsey
Utrecht University
Co-authored papers
1
Fatima Cardoso
Champalimaud Clinical Center/Champalimaud Foundation
Co-authored papers
1
Peter M A Sloot
Institute for Advanced Study, University of Amsterdam.
Co-authored papers
1
1 - 28